Stock Screener
Stock Research
Market Indexes
Precious Metals
Energy
Commodities
Interest Rates
Economy
Global Metrics

AstraZeneca EBITDA 2010-2025 | AZN

AstraZeneca annual and quarterly EBITDA history from 2010 to 2025. EBITDA can be defined as earnings before interest, taxes, depreciation and amortization.
  • AstraZeneca EBITDA for the quarter ending March 31, 2025 was $4.958B, a 13.46% increase year-over-year.
  • AstraZeneca EBITDA for the twelve months ending March 31, 2025 was $17.279B, a 24.32% increase year-over-year.
  • AstraZeneca 2024 annual EBITDA was $16.691B, a 22.91% increase from 2023.
  • AstraZeneca 2023 annual EBITDA was $13.58B, a 47.02% increase from 2022.
  • AstraZeneca 2022 annual EBITDA was $9.237B, a 21.76% increase from 2021.
  
AstraZeneca Annual EBITDA
(Millions of US $)
2024 $16,691
2023 $13,580
2022 $9,237
2021 $7,586
2020 $8,311
2019 $6,686
2018 $7,140
2017 $6,713
2016 $7,259
2015 $6,966
2014 $5,419
2013 $8,295
2012 $10,666
2011 $15,345
2010 $14,235
2009 $13,630
AstraZeneca Quarterly EBITDA
(Millions of US $)
2025-03-31 $4,958
2024-12-31 $4,373
2024-09-30 $3,923
2024-06-30 $4,025
2024-03-31 $4,370
2023-12-31 $2,561
2023-09-30 $3,236
2023-06-30 $3,732
2023-03-31 $4,051
2022-12-31 $2,575
2022-09-30 $2,579
2022-06-30 $1,896
2022-03-31 $2,187
2021-12-31 $1,900
2021-09-30 $1,114
2021-06-30 $1,880
2021-03-31 $2,692
2020-12-31 $2,284
2020-09-30 $1,972
2020-06-30 $1,994
2020-03-31 $2,061
2019-12-31 $2,220
2019-09-30 $1,473
2019-06-30 $1,220
2019-03-31 $1,773
2018-12-31 $2,739
2018-09-30 $1,549
2018-06-30 $1,447
2018-03-31 $1,405
2017-12-31 $1,793
2017-09-30 $1,804
2017-06-30 $1,541
2017-03-31 $1,575
2016-12-31 $3,123
2016-09-30 $1,639
2016-06-30 $890
2016-03-31 $1,607
2015-12-31 $1,804
2015-09-30 $1,741
2015-06-30 $1,639
2015-03-31 $1,782
2014-12-31 $672
2014-09-30 $1,392
2014-06-30 $1,807
2014-03-31 $1,548
2013-12-31 $2,014
2013-09-30 $2,094
2013-06-30 $2,139
2013-03-31 $2,048
2012-12-31 $2,728
2012-09-30 $2,901
2012-06-30 $2,378
2012-03-31 $2,659
2011-12-31 $3,137
2011-09-30 $4,805
2011-06-30 $3,476
2011-03-31 $3,927
2010-12-31 $4,136
2010-09-30 $3,008
2010-06-30 $3,299
2010-03-31 $3,792
2009-12-31 $3,738
2009-09-30 $3,608
2009-06-30 $3,001
2009-03-31 $3,283
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $232.596B $54.073B
AstraZeneca plc, is one of the largest biopharmaceutical companies in the world. AstraZeneca's business can be broken down into separate lines based on therapeutic classes. These include cardiovascular, respiratory, immunology, oncology, rare diseases and other.In July 2021 AstraZeneca closed the acquisition of rare disease drugmaker, Alexion. The acquisition added Alexion's five marketed rare disease products and its pipeline of immune-mediated rare disease candidates.In order to bolster its respiratory portfolio, AstraZeneca acquired rights to Allergan's branded respiratory business in the U.S. and Canada in Mar 2015. The company also acquired Takeda's core respiratory business in May 2016.In June 2007, AstraZeneca acquired biotechnology company MedImmune. In Aug 2011, AstraZeneca sold its Astra Tech business to DENTSPLY. AstraZeneca entered into a number of deals and struck agreements with companies such as FibroGen and Daiichi Sankyo.
Stock Name Country Market Cap PE Ratio
Amgen (AMGN) United States $159.855B 14.32
Gilead Sciences (GILD) United States $139.382B 14.48
Vertex Pharmaceuticals (VRTX) United States $118.142B 0.00
Bristol Myers Squibb (BMY) United States $103.158B 6.91
GSK (GSK) United Kingdom $87.087B 10.41
CSL (CSLLY) Australia $76.641B 0.00
Regeneron Pharmaceuticals (REGN) United States $56.341B 13.68
Alnylam Pharmaceuticals (ALNY) United States $39.725B 0.00
Argenex SE (ARGX) Netherlands $35.827B 97.79
BioNTech SE (BNTX) Germany $25.222B 0.00
Royalty Pharma (RPRX) United States $19.830B 8.38
Biogen (BIIB) United States $19.387B 8.36
Insmed (INSM) United States $17.646B 0.00
Genmab (GNMSF) Denmark $14.821B 15.15
Genmab (GMAB) Denmark $14.806B 16.61
Illumina (ILMN) United States $13.951B 26.47
Incyte (INCY) United States $13.399B 101.79
Exelixis (EXEL) United States $11.394B 19.34
Swedish Orphan Biovitrum (BIOVF) Sweden $11.389B 29.08
BioMarin Pharmaceutical (BMRN) United States $10.985B 17.84
Moderna (MRNA) United States $10.577B 0.00
QIAGEN (QGEN) Netherlands $10.534B 20.50
Ascendis Pharma (ASND) Denmark $10.442B 0.00
Exact Sciences (EXAS) United States $10.188B 0.00
Blueprint Medicines (BPMC) United States $8.280B 0.00
Bio-Techne Corp (TECH) United States $8.078B 30.14
Regencell Bioscience Holdings (RGC) Hong Kong, SAR China $7.944B 0.00
Verona Pharma American Depositary Share (VRNA) United Kingdom $7.874B 0.00
Roivant Sciences (ROIV) United Kingdom $7.797B 0.00
Revolution Medicines (RVMD) United States $7.657B 0.00
Repligen (RGEN) United States $7.377B 82.58
Legend Biotech (LEGN) United States $6.966B 0.00
Bio-Rad Laboratories (BIO.B) United States $6.805B 23.68
Halozyme Therapeutics (HALO) United States $6.720B 12.86
Jazz Pharmaceuticals (JAZZ) Ireland $6.674B 6.55
Guardant Health (GH) United States $6.073B 0.00
TG Therapeutics (TGTX) United States $5.933B 155.71
Telix Pharmaceuticals (TLX) Australia $5.903B 0.00
Nuvalent (NUVL) United States $5.595B 0.00
Zealand Pharma (ZLDPF) Denmark $5.265B 0.00
Axsome Therapeutics (AXSM) United States $5.231B 0.00
ADMA Biologics Inc (ADMA) United States $5.157B 38.57
Alkermes (ALKS) Ireland $5.076B 13.62
Zai Lab (ZLAB) China $4.747B 0.00
Vaxcyte (PCVX) United States $4.445B 0.00
Akero Therapeutics (AKRO) United States $4.270B 0.00
Krystal Biotech (KRYS) United States $4.055B 31.25
PTC Therapeutics (PTCT) United States $4.041B 7.03
Rhythm Pharmaceuticals (RYTM) United States $4.009B 0.00
Cytokinetics (CYTK) United States $3.965B 0.00
Avidity Biosciences (RNA) United States $3.874B 0.00
Merus (MRUS) Netherlands $3.834B 0.00
Ultragenyx Pharmaceutical (RARE) United States $3.715B 0.00
Sarepta Therapeutics (SRPT) United States $3.667B 0.00
Arcellx (ACLX) United States $3.665B 0.00
ACADIA Pharmaceuticals (ACAD) United States $3.638B 31.97
Metsera (MTSR) United States $3.633B 0.00
CRISPR Therapeutics AG (CRSP) Switzerland $3.565B 0.00
SpringWorks Therapeutics (SWTX) United States $3.523B 0.00
Protagonist Therapeutics (PTGX) United States $3.491B 75.09
Viking Therapeutics (VKTX) United States $3.210B 0.00
Scholar Rock Holding (SRRK) United States $3.164B 0.00
HUTCHMED (China) (HCM) Hong Kong, SAR China $3.089B 0.00
Kymera Therapeutics (KYMR) United States $3.080B 0.00
Alvotech (ALVO) Luxembourg $2.967B 16.97
MoonLake Immunotherapeutics (MLTX) Switzerland $2.818B 0.00
ImmunityBio (IBRX) United States $2.816B 0.00
Ascentage Pharma Group - (AAPG) China $2.789B 0.00
Immunovant (IMVT) United States $2.725B 0.00
Xenon Pharmaceuticals (XENE) Canada $2.517B 0.00
Mirum Pharmaceuticals (MIRM) United States $2.428B 0.00
Apellis Pharmaceuticals (APLS) United States $2.421B 0.00
Bavarian Nordic (BVNRY) Denmark $2.245B 11.86
Arrowhead Pharmaceuticals (ARWR) United States $2.240B 0.00
Ligand Pharmaceuticals (LGND) United States $2.208B 0.00
Denali Therapeutics (DNLI) United States $2.168B 0.00
Vericel (VCEL) United States $2.139B 1416.00
NovoCure (NVCR) Jersey $2.029B 0.00
Kiniksa Pharmaceuticals (KNSA) United Kingdom $2.023B 0.00
CG Oncology (CGON) United States $2.020B 0.00
Twist Bioscience (TWST) United States $2.015B 0.00
Agios Pharmaceuticals (AGIO) United States $1.998B 0.00
Belite Bio (BLTE) United States $1.978B 0.00
IDEAYA Biosciences (IDYA) United States $1.951B 0.00
Apogee Therapeutics (APGE) United States $1.928B 0.00
Harmony Biosciences Holdings (HRMY) United States $1.914B 12.72
Amicus Therapeutics (FOLD) United States $1.900B 205.67
Disc Medicine (IRON) United States $1.826B 0.00
Certara (CERT) United States $1.814B 33.88
Immunocore Holdings (IMCR) United Kingdom $1.790B 0.00
Beam Therapeutics (BEAM) United States $1.754B 0.00
Tarsus Pharmaceuticals (TARS) United States $1.720B 0.00
Edgewise Therapeutics (EWTX) United States $1.622B 0.00
Arcutis Biotherapeutics (ARQT) United States $1.609B 0.00
Biohaven (BHVN) United States $1.592B 0.00
Adaptive Biotechnologies (ADPT) United States $1.581B 0.00
Mesoblast (MESO) Australia $1.554B 0.00
BGM Group (BGM) China $1.518B 0.00
Janux Therapeutics (JANX) United States $1.513B 0.00
GRAIL (GRAL) United States $1.508B 0.00
Vera Therapeutics (VERA) United States $1.436B 0.00
89BIO (ETNB) United States $1.404B 0.00
Celldex Therapeutics (CLDX) United States $1.351B 0.00
ANI Pharmaceuticals (ANIP) United States $1.346B 13.87
Travere Therapeutics (TVTX) United States $1.327B 0.00
Viridian Therapeutics (VRDN) United States $1.279B 0.00
Structure Therapeutics (GPCR) United States $1.274B 0.00
Anbio Biotechnology (NNNN) Germany $1.266B 0.00
CureVac (CVAC) Germany $1.256B 6.09
Dynavax Technologies (DVAX) United States $1.249B 74.29
Liquidia Technologies (LQDA) United States $1.235B 0.00
MannKind (MNKD) United States $1.164B 23.94
Novavax (NVAX) United States $1.158B 2.70
Pacira BioSciences (PCRX) United States $1.132B 10.77
Niagen Bioscience (NAGE) United States $1.114B 157.11
WAVE Life Sciences (WVE) Singapore $1.110B 0.00
Spyre Therapeutics (SYRE) United States $1.067B 0.00
CorMedix Inc (CRMD) United States $1.008B 67.54
Geron (GERN) United States $0.994B 0.00
Arcus Biosciences (RCUS) United States $0.990B 0.00
Mineralys Therapeutics (MLYS) United States $0.972B 0.00
NeoGenomics (NEO) United States $0.951B 0.00
AbCellera Biologics (ABCL) Canada $0.940B 0.00
Syndax Pharmaceuticals (SNDX) United States $0.918B 0.00
Praxis Precision Medicines (PRAX) United States $0.917B 0.00
Nurix Therapeutics (NRIX) United States $0.912B 0.00
Zymeworks (ZYME) United States $0.911B 0.00
MiMedx (MDXG) United States $0.904B 21.86
Pharvaris (PHVS) Netherlands $0.901B 0.00
UniQure (QURE) Netherlands $0.876B 0.00
Intellia Therapeutics (NTLA) United States $0.865B 0.00
Oculis Holding AG (OCS) Switzerland $0.859B 0.00
Immunome (IMNM) United States $0.852B 0.00
LENZ Therapeutics (LENZ) United States $0.833B 0.00
Oric Pharmaceuticals (ORIC) United States $0.824B 0.00
Cogent Biosciences (COGT) United States $0.822B 0.00
ArriVent BioPharma (AVBP) United States $0.808B 0.00
Pharming Group (PHGUF) Netherlands $0.795B 0.00
Pharming Group (PHAR) Netherlands $0.787B 0.00
Iovance Biotherapeutics (IOVA) United States $0.771B 0.00
Replimune (REPL) United States $0.762B 0.00
Basilea Pharmaceutica AG (BPMUF) Switzerland $0.760B 0.00
Gyre Therapeutics (GYRE) United States $0.757B 201.75
Sionna Therapeutics (SION) United States $0.750B 0.00
Immatics (IMTX) Germany $0.746B 0.00
Trevi Therapeutics (TRVI) United States $0.724B 0.00
Vir Biotechnology (VIR) United States $0.722B 0.00
Anavex Life Sciences (AVXL) United States $0.702B 0.00
Phathom Pharmaceuticals (PHAT) United States $0.700B 0.00
AnaptysBio (ANAB) United States $0.688B 0.00
Arbutus Biopharma (ABUS) United States $0.686B 0.00
Day One Biopharmaceuticals (DAWN) United States $0.678B 0.00
GH Research (GHRS) Ireland $0.668B 0.00
Stoke Therapeutics (STOK) United States $0.645B 14.96
Sinovac Biotech (SVA) China $0.645B 0.00
Bicara Therapeutics (BCAX) United States $0.631B 0.00
Upstream Bio (UPB) United States $0.622B 0.00
Dianthus Therapeutics (DNTH) United States $0.620B 0.00
Nuvation Bio (NUVB) United States $0.616B 0.00
EYEPOINT PHARMACEUTICALS, INC (EYPT) United States $0.610B 0.00
Bicycle Therapeutics (BCYC) United Kingdom $0.602B 0.00
Maze Therapeutics (MAZE) United States $0.593B 0.00
Kura Oncology (KURA) United States $0.577B 0.00
Sana Biotechnology (SANA) United States $0.573B 0.00
Autolus Therapeutics (AUTL) United Kingdom $0.572B 0.00
Fortrea Holdings (FTRE) United States $0.567B 15.68
Keros Therapeutics (KROS) United States $0.554B 0.00
Arvinas (ARVN) United States $0.553B 0.00
Mind Medicine (MindMed) (MNMD) United States $0.552B 0.00
Tyra Biosciences (TYRA) United States $0.548B 0.00
Tango Therapeutics (TNGX) United States $0.547B 0.00
Ginkgo Bioworks Holdings (DNA) United States $0.544B 0.00
Castle Biosciences (CSTL) United States $0.543B 36.90
MeiraGTx Holdings (MGTX) United States $0.530B 0.00
Cullinan Therapeutics (CGEM) United States $0.528B 0.00
Opthea (OPT) Australia $0.525B 0.00
REGENXBIO (RGNX) United States $0.512B 0.00
Urogen Pharma (URGN) United States $0.511B 0.00
Oxford BioMedica (OXBDF) United Kingdom $0.494B 0.00
ATyr Pharma (ATYR) United States $0.483B 0.00
Myriad Genetics (MYGN) United States $0.478B 0.00
Celcuity (CELC) United States $0.476B 0.00
Zenas BioPharma (ZBIO) United States $0.474B 0.00
PureTech Health (PRTC) United States $0.471B 0.00
Septerna (SEPN) United States $0.464B 0.00
Precigen (PGEN) United States $0.449B 0.00
Abivax SA (ABVX) France $0.445B 0.00
Mereo BioPharma Group - (MREO) United Kingdom $0.442B 0.00
Erasca (ERAS) United States $0.433B 0.00
Cytek Biosciences (CTKB) United States $0.426B 0.00
Tectonic Therapeutic (TECX) United States $0.419B 0.00
Benitec Biopharma (BNTC) United States $0.418B 0.00
Sage Therapeutics (SAGE) United States $0.413B 0.00
Rapport Therapeutics (RAPP) United States $0.407B 0.00
Kamada (KMDA) Israel $0.399B 23.93
Eton Pharmaceuticals (ETON) United States $0.389B 0.00
ITeos Therapeutics (ITOS) United States $0.382B 0.00
Northwest Biotherapeutics (NWBO) United States $0.378B 0.00
Rezolute (RZLT) United States $0.376B 0.00
Humacyte (HUMA) United States $0.374B 0.00
Checkpoint Therapeutics (CKPT) United States $0.371B 0.00
Vigil Neuroscience (VIGL) United States $0.367B 0.00
Fulcrum Therapeutics (FULC) United States $0.366B 0.00
ADC Therapeutics SA (ADCT) Switzerland $0.364B 0.00
Absci (ABSI) United States $0.362B 0.00
MBX Biosciences (MBX) United States $0.358B 0.00
Emergent Biosolutions (EBS) United States $0.358B 0.00
Solid Biosciences (SLDB) United States $0.355B 0.00
Ocugen (OCGN) United States $0.350B 0.00
Zhengye Biotechnology Holding (ZYBT) China $0.344B 0.00
Terns Pharmaceuticals (TERN) United States $0.343B 0.00
Arcturus Therapeutics Holdings (ARCT) United States $0.343B 0.00
Aura Biosciences (AURA) United States $0.335B 0.00
Compass Therapeutics (CMPX) United States $0.333B 0.00
Rocket Pharmaceuticals (RCKT) United States $0.328B 0.00
Inventiva S.A (IVA) France $0.325B 0.00
Verastem (VSTM) United States $0.323B 0.00
Abeona Therapeutics (ABEO) United States $0.319B 0.00
Astria Therapeutics (ATXS) United States $0.316B 0.00
Alpha Teknova (TKNO) United States $0.310B 0.00
Allogene Therapeutics (ALLO) United States $0.306B 0.00
Cidara Therapeutics (CDTX) United States $0.304B 0.00
Monte Rosa Therapeutics (GLUE) United States $0.303B 61.50
Entrada Therapeutics (TRDA) United States $0.298B 9.69
Annexon (ANNX) United States $0.297B 0.00
XOMA Royalty (XOMA) United States $0.294B 0.00
Palvella Therapeutics (PVLA) United States $0.292B 0.00
Neurogene (NGNE) United States $0.291B 0.00
Corvus Pharmaceuticals (CRVS) United States $0.289B 0.00
Gossamer Bio (GOSS) United States $0.289B 0.00
Olema Pharmaceuticals (OLMA) United States $0.278B 0.00
Amarin (AMRN) Ireland $0.277B 0.00
Atea Pharmaceuticals (AVIR) United States $0.275B 0.00
Prothena (PRTA) Ireland $0.273B 0.00
Vanda Pharmaceuticals (VNDA) United States $0.273B 0.00
Candel Therapeutics (CADL) United States $0.269B 0.00
2seventy Bio (TSVT) United States $0.266B 0.00
Cartesian Therapeutics (RNAC) United States $0.266B 0.00
DBV Technologies S.A (DBVT) France $0.265B 0.00
Sagimet Biosciences (SGMT) United States $0.264B 0.00
Inozyme Pharma (INZY) United States $0.257B 0.00
Foghorn Therapeutics (FHTX) United States $0.253B 0.00
Lifecore Biomedical (LFCR) United States $0.253B 0.00
Prima BioMed (IMMP) Australia $0.253B 0.00
Cardiff Oncology (CRDF) United States $0.252B 0.00
Lexicon Pharmaceuticals (LXRX) United States $0.252B 0.00
Instil Bio (TIL) United States $0.246B 0.00
Tvardi Therapeutics (TVRD) United States $0.244B 0.00
Third Harmonic Bio (THRD) United States $0.244B 0.00
MaxCyte (MXCT) United States $0.242B 0.00
CytomX Therapeutics (CTMX) United States $0.241B 6.23
Aardvark Therapeutics (AARD) United States $0.240B 0.00
Semper Paratus Acquisition (TVGN) United States $0.234B 0.00
BioStem Technologies (BSEM) $0.232B 9.46
Adherex Technologies (FENC) United States $0.230B 0.00
ACELYRIN, INC (SLRN) United States $0.229B 0.00
Design Therapeutics (DSGN) United States $0.222B 0.00
Adocia (ADOCY) France $0.213B 0.00
ScPharmaceuticals (SCPH) United States $0.211B 0.00
I-Mab (IMAB) United States $0.211B 0.00
Y-mAbs Therapeutics (YMAB) United States $0.210B 0.00
AC Immune (ACIU) Switzerland $0.208B 0.00
Inhibrx Biosciences (INBX) United States $0.207B 0.12
Monopar Therapeutics (MNPR) United States $0.207B 0.00
CARGO Therapeutics (CRGX) United States $0.207B 0.00
ProQR Therapeutics (PRQR) Netherlands $0.204B 0.00
GENFIT S.A (GNFT) France $0.201B 0.00
Bright Minds Biosciences (DRUG) United States $0.200B 0.00
Voyager Therapeutics (VYGR) United States $0.199B 0.00
Kodiak Sciences (KOD) United States $0.194B 0.00
Prime Medicine (PRME) United States $0.192B 0.00
Codexis (CDXS) United States $0.186B 0.00
Nuvectis Pharma (NVCT) United States $0.184B 0.00
Editas Medicine (EDIT) United States $0.182B 0.00
Innate Pharma S.A (IPHA) France $0.182B 0.00
INmune Bio (INMB) United States $0.182B 0.00
Eledon Pharmaceuticals (ELDN) United States $0.180B 0.00
Ventyx Biosciences (VTYX) United States $0.177B 0.00
Puma Biotechnology (PBYI) United States $0.177B 4.62
Actuate Therapeutics (ACTU) United States $0.169B 0.00
DiaMedica Therapeutics (DMAC) United States $0.167B 0.00
Tiziana Life Sciences (TLSA) United Kingdom $0.166B 0.00
EnGene Holdings (ENGN) Canada $0.166B 0.00
Galena Biopharma (SLS) United States $0.165B 0.00
Alector (ALEC) United States $0.162B 0.00
Anika Therapeutics (ANIK) United States $0.162B 0.00
Spero Therapeutics (SPRO) United States $0.162B 0.00
BioAge Labs (BIOA) United States $0.161B 0.00
Fate Therapeutics (FATE) United States $0.160B 0.00
Molecular Partners AG (MOLN) Switzerland $0.157B 0.00
Alpha Cognition (ACOG) Canada $0.154B 0.00
Alumis (ALMS) United States $0.150B 0.00
Kyverna Therapeutics (KYTX) United States $0.150B 0.00
Compugen (CGEN) Israel $0.148B 0.00
Neumora Therapeutics (NMRA) United States $0.145B 0.00
Rapt Therapeutics (RAPT) United States $0.144B 0.00
Eupraxia Pharmaceuticals (EPRX) Canada $0.140B 0.00
Black Diamond Therapeutics (BDTX) United States $0.138B 40.50
23andMe Holding (MEHCQ) United States $0.138B 0.00
Nkarta (NKTX) United States $0.136B 0.00
Agenus (AGEN) United States $0.132B 0.00
Elicio Therapeutics (ELTX) United States $0.128B 0.00
Greenwich LifeSciences (GLSI) United States $0.127B 0.00
BioHarvest Sciences (BHST) Canada $0.126B 0.00
Seer (SEER) United States $0.125B 0.00
Orchestra BioMed Holdings (OBIO) United States $0.121B 0.00
Contineum Therapeutics (CTNM) United States $0.120B 0.00
Cuprina Holdings (Cayman) (CUPR) Singapore $0.119B 0.00
Sangamo Therapeutics (SGMO) United States $0.117B 0.00
Theratechnologies (THTX) Canada $0.116B 0.00
ANIXA BIOSCIENCES INC (ANIX) United States $0.116B 0.00
C4 Therapeutics (CCCC) United States $0.115B 0.00
TuHURA Biosciences (HURA) United States $0.114B 0.00
BeyondSpring (BYSI) United States $0.114B 0.00
EXoZymes (EXOZ) United States $0.110B 0.00
Caribou Biosciences (CRBU) United States $0.108B 0.00
Citius Oncology (CTOR) United States $0.105B 0.00
Zentalis Pharmaceuticals (ZNTL) United States $0.105B 0.00
Invivyd (IVVD) United States $0.102B 0.00
Genelux (GNLX) United States $0.100B 0.00
IO Biotech (IOBT) Denmark $0.099B 0.00
Biomea Fusion (BMEA) United States $0.098B 0.00
Prenetics Global (PRE) Hong Kong, SAR China $0.098B 0.00
Tenaya Therapeutics (TNYA) United States $0.098B 0.00
HilleVax (HLVX) United States $0.096B 0.00
Whitehawk Therapeutics (WHWK) United States $0.096B 0.00
Entera Bio (ENTX) Israel $0.095B 0.00
Adagene (ADAG) China $0.092B 0.00
Coherus Oncology (CHRS) United States $0.092B 0.00
Cabaletta Bio (CABA) United States $0.091B 0.00
TScan Therapeutics (TCRX) United States $0.091B 0.00
Pliant Therapeutics (PLRX) United States $0.090B 0.00
Nautilus Biotechnology (NAUT) United States $0.090B 0.00
Milestone Pharmaceuticals (MIST) Canada $0.090B 0.00
Coya Therapeutics (COYA) United States $0.090B 0.00
Climb Bio (CLYM) United States $0.087B 0.00
OKYO Pharma (OKYO) $0.086B 0.00
XBiotech (XBIT) United States $0.084B 0.00
Jasper Therapeutics (JSPR) United States $0.084B 0.00
Zura Bio (ZURA) United States $0.083B 0.00
Forte Biosciences (FBRX) United States $0.083B 0.00
PDS Biotechnology (PDSB) United States $0.082B 0.00
Immunic (IMUX) United States $0.081B 0.00
Elutia (ELUT) United States $0.078B 0.00
Inovio Pharmaceuticals (INO) United States $0.076B 0.00
Cellectis S.A (CLLS) France $0.076B 0.00
Senti Biosciences (SNTI) United States $0.075B 0.00
TELA Bio (TELA) United States $0.073B 0.00
IGM Biosciences (IGMS) United States $0.072B 0.00
Genenta Science S.p.A (GNTA) Italy $0.071B 0.00
Immuneering (IMRX) United States $0.071B 0.00
Seres Therapeutics (MCRB) United States $0.070B 0.00
Immix Biopharma (IMMX) United States $0.069B 0.00
Acumen Pharmaceuticals (ABOS) United States $0.069B 0.00
Sutro Biopharma (STRO) United States $0.069B 0.00
MediciNova (MNOV) United States $0.068B 0.00
Skye Bioscience (SKYE) United States $0.067B 0.00
VistaGen Therapeutics (VTGN) United States $0.067B 0.00
Alto Neuroscience (ANRO) United States $0.066B 0.00
CervoMed (CRVO) United States $0.066B 0.00
Ikena Oncology (IKNA) United States $0.066B 0.00
Renovaro (RENB) United States $0.065B 0.00
Adaptimmune Therapeutics (ADAP) United Kingdom $0.065B 0.00
Adicet Bio (ACET) United States $0.065B 0.00
Akoya Biosciences (AKYA) United States $0.063B 0.00
Clearside Biomedical (CLSD) United States $0.063B 0.00
Repare Therapeutics (RPTX) Canada $0.062B 0.00
Oncobiologics (OTLK) United States $0.062B 0.00
Achilles Therapeutics (ACHL) United Kingdom $0.061B 0.00
Opus Genetics (IRD) United States $0.059B 0.00
Adlai Nortye (ANL) Cayman Islands $0.059B 0.00
Fortress Biotech (FBIO) United States $0.058B 0.00
Werewolf Therapeutics (HOWL) United States $0.058B 0.00
Annovis Bio (ANVS) United States $0.057B 0.00
Exicure (XCUR) United States $0.057B 0.00
Precision BioSciences (DTIL) United States $0.056B 0.00
Quince Therapeutics (QNCX) United States $0.055B 0.00
Adverum Biotechnologies (ADVM) United States $0.054B 0.00
Kronos Bio (KRON) United States $0.054B 0.00
InflaRx (IFRX) Germany $0.054B 0.00
ZIVO Bioscience (ZIVO) United States $0.053B 0.00
Anebulo Pharmaceuticals (ANEB) United States $0.052B 0.00
Atara Biotherapeutics (ATRA) United States $0.052B 0.00
Applied Therapeutics (APLT) United States $0.052B 0.00
Kalaris Therapeutics (KLRS) United States $0.052B 0.00
Quantum Biopharma (QNTM) Canada $0.051B 0.00
Shattuck Labs (STTK) United States $0.051B 0.00
VTv Therapeutics (VTVT) United States $0.051B 0.00
Oncolytics Biotech (ONCY) Canada $0.050B 0.00
Artiva Biotherapeutics (ARTV) United States $0.050B 0.00
RenovoRx (RNXT) United States $0.050B 0.00
Aligos Therapeutics (ALGS) United States $0.049B 0.00
Bluebird Bio (BLUE) United States $0.049B 0.00
PepGen (PEPG) United States $0.048B 0.00
Cue Biopharma (CUE) United States $0.048B 0.00
Connect Biopharma Holdings (CNTB) United States $0.047B 0.00
Mersana Therapeutics (MRSN) United States $0.045B 0.00
Rein Therapeutics (RNTX) United States $0.044B 0.00
Celularity (CELU) United States $0.042B 0.00
Alterity Therapeutics - (ATHE) Australia $0.041B 0.00
Biodexa Pharmaceuticals (BDRX) United Kingdom $0.040B 0.00
Radiopharm Theranostics - (RADX) Australia $0.040B 0.00
OnKure Therapeutics (OKUR) United States $0.039B 0.00
Medicus Pharma (MDCX) United States $0.038B 0.00
Akari Therapeutics (AKTX) United Kingdom $0.038B 0.00
Barinthus Biotherapeutics (BRNS) United Kingdom $0.037B 0.00
Clene (CLNN) United States $0.037B 0.00
Estrella Immunopharma (ESLA) United States $0.037B 0.00
Scilex Holding (SCLX) United States $0.036B 0.00
Xilio Therapeutics (XLO) United States $0.035B 0.00
Kezar Life Sciences (KZR) United States $0.035B 0.00
Lantern Pharma (LTRN) United States $0.035B 0.00
LAVA Therapeutics (LVTX) Netherlands $0.034B 0.00
AN2 Therapeutics (ANTX) United States $0.034B 0.00
Pluri (PLUR) Israel $0.034B 0.00
FibroBiologics (FBLG) United States $0.033B 0.00
NeuroSense Therapeutics (NRSN) Israel $0.033B 0.00
Rani Therapeutics Holdings (RANI) United States $0.032B 0.00
CAMP4 Therapeutics (CAMP) United States $0.032B 0.00
ABVC BioPharma (ABVC) United States $0.031B 0.00
MiNK Therapeutics (INKT) United States $0.030B 0.00
Allakos (ALLK) United States $0.030B 0.00
Grace Therapeutics (GRCE) Canada $0.030B 0.00
Coeptis Therapeutics Holdings (COEP) United States $0.030B 0.00
Cadrenal Therapeutics (CVKD) United States $0.029B 0.00
Curis (CRIS) United States $0.029B 0.00
ALX Oncology Holdings (ALXO) United States $0.029B 0.00
KALA BIO (KALA) United States $0.029B 0.00
Imunon (IMNN) United States $0.028B 0.00
Dyadic (DYAI) United States $0.028B 0.00
Dare Bioscience (DARE) United States $0.028B 0.00
Passage Bio (PASG) United States $0.027B 0.00
Vor Biopharma (VOR) $0.026B 0.00
Generation Bio (GBIO) United States $0.026B 0.00
BioAtla (BCAB) United States $0.025B 0.00
CalciMedica (CALC) United States $0.024B 0.00
Boundless Bio (BOLD) United States $0.024B 0.00
Tenax Therapeutics (TENX) United States $0.024B 0.00
Femasys (FEMY) United States $0.024B 0.00
Chemomab Therapeutics (CMMB) Israel $0.023B 0.00
Elevation Oncology (ELEV) United States $0.023B 0.00
Lisata Therapeutics (LSTA) United States $0.022B 0.00
Gelteq (GELS) Australia $0.022B 0.00
MIRA Pharmaceuticals (MIRA) United States $0.021B 0.00
Q32 Bio (QTTB) United States $0.021B 0.00
Advanced Biomed (ADVB) United States $0.021B 0.00
Ovid Therapeutics (OVID) United States $0.021B 0.00
Longeveron (LGVN) United States $0.020B 0.00
CollPlant Biotechnologies (CLGN) Israel $0.019B 0.00
Cognition Therapeutics (CGTX) United States $0.019B 0.00
Aspire Biopharma Holdings (ASBP) United States $0.019B 0.00
Hoth Therapeutics (HOTH) United States $0.019B 0.00
Cingulate (CING) United States $0.019B 0.00
NextCure (NXTC) United States $0.018B 0.00
Lexaria Bioscience (LEXX) Canada $0.018B 0.00
X4 Pharmaceuticals (XFOR) United States $0.018B 0.00
Leap Therapeutics (LPTX) United States $0.018B 0.00
GeoVax Labs (GOVX) United States $0.017B 0.00
HOOKIPA Pharma (HOOK) United States $0.017B 0.00
IBio (IBIO) United States $0.017B 0.00
SAB Biotherapeutics (SABS) United States $0.017B 0.00
Promis Neurosciences (PMN) Canada $0.017B 0.00
Beyond Air (XAIR) United States $0.016B 0.00
Biorestorative Therapies (BRTX) United States $0.015B 0.00
UNITY Biotechnology (UBX) United States $0.015B 0.00
MetaVia (MTVA) United States $0.015B 0.00
Synlogic (SYBX) United States $0.014B 0.00
Abpro Holdings (ABP) United States $0.014B 0.00
Equillium (EQ) United States $0.014B 0.00
Rallybio (RLYB) United States $0.014B 0.00
Edesa Biotech (EDSA) Canada $0.014B 0.00
Neuphoria Therapeutics (NEUP) Australia $0.013B 0.00
BRIACELL THERAP (BCTX) Canada $0.013B 0.00
Allarity Therapeutics (ALLR) United States $0.013B 0.00
Bionano Genomics (BNGO) United States $0.012B 0.00
Lipella Pharmaceuticals (LIPO) United States $0.012B 0.00
Athira Pharma (ATHA) United States $0.012B 0.00
Aytu BioPharma (AYTU) United States $0.012B 0.00
Bolt Biotherapeutics (BOLT) United States $0.012B 0.00
BioCardia (BCDA) United States $0.011B 0.00
COSCIENS Biopharma (CSCI) Canada $0.011B 0.00
BioXcel Therapeutics (BTAI) United States $0.011B 0.00
Aprea Therapeutics (APRE) United States $0.011B 0.00
IMMURON (IMRN) Australia $0.010B 0.00
Cyclerion Therapeutics (CYCN) United States $0.010B 0.00
Dogwood Therapeutics (DWTX) United States $0.010B 0.00
Novogen (KZIA) Australia $0.010B 0.00
Moleculin Biotech (MBRX) United States $0.009B 0.00
Brainstorm Cell Therapeutics (BCLI) United States $0.009B 0.00
LakeShore Biopharma (LSB) China $0.009B 0.00
GENPREX (GNPX) United States $0.009B 0.00
BioAffinity Technologies (BIAF) United States $0.009B 0.00
Sensei Biotherapeutics (SNSE) United States $0.008B 0.00
Turnstone Biologics (TSBX) United States $0.008B 0.00
Evogene (EVGN) Israel $0.008B 0.00
Cyclacel Pharmaceuticals (CYCC) $0.008B 0.00
HCW Biologics (HCWB) United States $0.008B 0.00
Acurx Pharmaceuticals (ACXP) United States $0.008B 0.00
Eyenovia (EYEN) United States $0.008B 0.00
Silexion Therapeutics Corp (SLXN) Israel $0.008B 0.00
Apollomics (APLM) United States $0.008B 0.00
GT Biopharma (GTBP) United States $0.007B 0.00
Sunshine Biopharma (SBFM) United States $0.007B 0.00
IN8bio (INAB) United States $0.007B 0.00
Cardio Diagnostics Holdings (CDIO) United States $0.007B 0.00
Mainz Biomed (MYNZ) Germany $0.007B 0.00
Synaptogenix (SNPX) United States $0.007B 0.00
Arcadia Biosciences (RKDA) United States $0.007B 0.00
Portage Biotech (PRTG) $0.007B 0.00
Pasithea Therapeutics (KTTA) United States $0.006B 0.00
Biofrontera (BFRI) United States $0.006B 0.00
Soligenix (SNGX) United States $0.006B 0.00
Intensity Therapeutics (INTS) United States $0.006B 0.00
Jade Biosciences (JBIO) United States $0.006B 0.00
Avalon GloboCare (ALBT) United States $0.006B 0.00
180 Life Sciences (ATNF) United States $0.006B 0.00
Polyrizon (PLRZ) Israel $0.006B 0.00
Creative Medical Technology Holdings (CELZ) United States $0.006B 0.00
Mustang Bio (MBIO) United States $0.006B 0.00
Ensysce Biosciences (ENSC) United States $0.005B 0.00
CNS Pharmaceuticals (CNSP) United States $0.005B 0.00
Onconetix (ONCO) United States $0.005B 0.00
Dermata Therapeutics (DRMA) United States $0.005B 0.00
VivoSim Labs (VIVS) United States $0.005B 0.00
Galecto (GLTO) Denmark $0.004B 0.00
Titan Pharmaceuticals (TTNP) United States $0.004B 0.00
Artelo Biosciences (ARTL) United States $0.004B 0.00
Sonnet BioTherapeutics Holdings (SONN) United States $0.004B 0.00
Tharimmune (THAR) United States $0.004B 0.00
Adial Pharmaceuticals (ADIL) United States $0.004B 0.00
Lixte Biotechnology Holdings (LIXT) United States $0.004B 0.00
ZyVersa Therapeutics (ZVSA) United States $0.003B 0.00
Palisade Bio (PALI) United States $0.003B 0.00
Purple Biotech (PPBT) Israel $0.003B 0.00
AquaBounty Technologies (AQB) United States $0.003B 0.00
Virax Biolabs Group (VRAX) United Kingdom $0.003B 0.00
Enveric Biosciences (ENVB) United States $0.003B 0.00
GRI Bio (GRI) United States $0.003B 0.00
Affimed (AFMD) Germany $0.003B 0.00
Bone Biologics (BBLG) United States $0.003B 0.00
Silo Pharma (SILO) United States $0.003B 0.00
Psyence Biomedical (PBM) Canada $0.003B 0.00
Entero Therapeutics (ENTO) United States $0.003B 0.00
Alzamend Neuro (ALZN) United States $0.003B 0.00
Scinai Immunotherapeutics (SCNI) Israel $0.002B 0.00
Windtree Therapeutics (WINT) United States $0.002B 0.00
Atrinsic (PTIX) United States $0.002B 0.00
Aptevo Therapeutics (APVO) United States $0.002B 0.00
NuCana (NCNA) United Kingdom $0.001B 0.00
Revelation Biosciences (REVB) United States $0.001B 0.00
Capstone Holding� (CAPS) United States $0.000B 0.00
Aceragen (ACGN) United States $0.000B 0.00
ARAVIVE, INC (ARAV) United States $0.000B 0.00
Clovis Oncology (CLVSQ) United States $0.000B 0.00
Cocrystal Pharma (COCP) United States $0.000B 0.00
Celyad SA (CYAD) Belgium $0.000B 0.00
CytoMed Therapeutics (GDTC) Singapore $0.000B 0.00
Galapagos (GLPG) Belgium $0.000B 0.00
Motif Bio Plc (MTFB) United Kingdom $0.000B 0.00
PDL BioPharma (PDLI) United States $0.000B 0.00
Pulmatrix (PULM) United States $0.000B 0.00
TFF Pharmaceuticals (TFFP) United States $0.000B 0.00
VectivBio Holding AG (VECT) Switzerland $0.000B 0.00